Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
2007
Mechanisms of Vascular Calcification
2007
Oral Phosphate Binders in Patients with Kidney Failure
2010
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
2005
Vascular Calcification
2009
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients
2002
Cardiorenal Syndrome
2008 Standout
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
2008
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
2007
Lipid-lowering therapy in patients with renal disease
1995
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
2007
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy
2006
Calcium supplementation and vascular disease
2008
Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients
2008
Chronic Kidney Disease
2016 Standout
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
2006
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Magnesium in Man: Implications for Health and Disease
2014 Standout
IGF-binding protein-5: flexible player in the IGF system and effector on its own
2002
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
Evaluating non-randomised intervention studies
2003 Standout
Vitamin D and Immune Function
2013 Standout
40 YEARS OF IGF1: Role of IGF-binding proteins in regulating IGF responses to changes in metabolism
2018
Vascular Calcification
2006 Standout
Bone metabolism and disease in chronic kidney disease
2003
Vascular Calcification
2008 Standout
Interventions for preventing falls in older people living in the community
2012 Standout
Works of Walter Schulz being referenced
FIXED DOSE COMBINATIONS OF ACE INHIBITORS
1996
Reduced lipid concentrations during four years of dialysis with low molecular weight heparin
1991
Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification
2004
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
2005
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients
2003
The Action of 1,25 (OH)2D3 on Turnover Kinetic, Remodelling Surfaces and Structure of Trabecular Bone in Chronic Renal Failure
2015
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000